Anticancer Water-Soluble Organoruthenium Complexes: Synthesis and Preclinical Evaluation

Area of Science:

• Inorganic Chemistry
• Medicinal Chemistry
• Cancer Research

Background:

• Ruthenium complexes are investigated for anticancer properties.
• Water-solubility is crucial for effective drug delivery and in vitro evaluation.
• Maleonitriledithiolate ligands offer a scaffold for developing novel metal-based therapeutics.

Purpose of the Study:

• To synthesize and characterize novel ruthenium metal complexes.
• To evaluate the in vitro cytotoxicity of these complexes against various cancer cell lines.
• To explore the mechanism of action and preliminary in vivo efficacy.

Main Methods:

• Synthesis of five maleonitriledithiolate-based ruthenium complexes with diverse phosphine ligands.
• In vitro cytotoxicity assays using ovarian (A2780, A2780cisR), lung (H460), and normal prostate (PNT2) cancer cell lines.
• Mechanism of action studies involving reactive oxygen species (ROS) detection.
• Preliminary in vivo studies using xenograft models.

Main Results:

• Complexes with triphenylphosphine-3,3',3''-trisulfonic acid and triphenylphosphine ligands demonstrated significant in vitro cytotoxicity against ovarian cancer cell lines.
• Cytotoxicity was comparable to the 16-electron precursor and effective against both sensitive and resistant cell lines.
• Evidence suggests apoptosis induction mediated by ROS production.
• Preliminary in vivo studies showed no toxicity and suggested tumor growth delay.

Conclusions:

• Water-soluble ruthenium complexes show potential as anticancer agents, particularly for ovarian cancer.
• The mechanism involves ROS-mediated apoptosis.
• Further investigation into these complexes for cancer therapy is warranted.